Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments (the eServices portal) close on Thursday 21 October at 4:30pm because of system upgrades. We expect to open them again on Friday 22 October at 8am the latest.

Development of novel vaccine therapy, based on intracellular direct antigen release nanocarriers

Reference number
Coordinator Lunds universitet - Institutionen för immunteknologi
Funding from Vinnova SEK 1 400 000
Project duration September 2007 - August 2009
Status Completed

Last updated 25 November 2019

Reference number 2007-00216

Page statistics